BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Neurocrine Biosciences, Inc. Announces Phase IIb Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia

  September 10, 2013

   · 

  12 min read
• Deals

  Cambridge Research Biochemicals Acquires Rights to Novel Technology Useful for Development of Gene and Drug Therapies

  September 10, 2013

   · 

  4 min read
• Genetown

  Metamark Genetics, Inc. Announces Positive Results of ProMark™ Prostate Cancer Clinical Validation Study

  September 10, 2013

   · 

  3 min read
• BioMidwest

  Perrigo Company to Present at Upcoming Healthcare Conferences

  September 10, 2013

   · 

  3 min read
• Bio NC

  Cempra Pharmaceuticals, Inc. to Present Data at ICAAC on Solithromycin’s (CEM-101) Activity Against a Broad Range of Pathogens Including Four Proposed or Designated by the Food and Drug Administration as Qualified Infectious Disease Pathogens (QIDP) Under

  September 10, 2013

   · 

  1 min read
• Biotech Bay

  Shin Nippon Biomedical Laboratories Release: Novel Nasal Epinephrine Shows Comparable Absorption to EpiPen® in a Feasibility Study

  September 10, 2013

   · 

  1 min read
• Imperial Innovations Leads £8 Million Series “C” Funding Round in Plaxica

  September 10, 2013

   · 

  5 min read
• Drug Development

  Constellation Pharmaceuticals Initiates Clinical Development of CPI-0610, a Novel BET Protein Bromodomain Inhibitor, in Patients With Lymphoma

  September 10, 2013

   · 

  1 min read
• Business

  Corgenix Medical Corporation Announces New AtherOx® (Oxidized LDL Technology) License and Cooperation Agreement

  September 10, 2013

   · 

  1 min read
• Business

  Bayer HealthCare and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy

  September 10, 2013

   · 

  5 min read